MMP2 and gastric cancer: It has been recently demonstrated that in gastric cancer cell lines, melatonin, by reducing the production of cellular ROS, induced a decrease in p-p65 expression level and of NF-κB target proteins Matrix Metalloproteinases 2 (MMP2) and cyclin D1, which are directly involved in cancer proliferation and metastasis [39].